NCT04752735View on ClinicalTrials.gov

Endovascular treatmenT for Acute Ischemic Stroke in China

CompletedOBSERVATIONAL
Enrollment

1,000

Participants

Timeline

Start Date

March 22, 2021

Primary Completion Date

February 8, 2023

Study Completion Date

February 8, 2023

Conditions
StrokeEndovascular Treatment
Interventions
OTHER

endovascular treatment

all enrolled patients must receive endovascular treatment.

Trial Locations (1)

110016

Department of Neurology, General Hospital of Northern Theater Command, Shenyang

All Listed Sponsors
lead

General Hospital of Shenyang Military Region

OTHER

NCT04752735 - Endovascular treatmenT for Acute Ischemic Stroke in China | Biotech Hunter | Biotech Hunter